Glofitamab monotherapy retreatment in patients with heavily pre-treated relapsed or refractory (R/R) non-Hodgkin lymphoma (NHL): Results from a phase I/II study

被引：0
|
作者：
Bartlett, Nancy L.
Dickinson, Michael
Hutchings, Martin
Carlo-Stella, Carmelo
Wu, Shang-Ju
Leppa, Sirpa
Trneny, Marek
Corradini, Paolo
Offner, Fritz
Mulvihill, Estefania
Bottos, Alessia
Chohan, Saibah
Baumlin, Pauline
Relf, James
Lundberg, Linda
Bachy, Emmanuel
机构：
[1] Washington Univ, St Louis, MO USA
[2] Peter MacCallum Canc Ctr, Melbourne, Australia
[3] Rigshosp, Copenhagen, Denmark
[4] Univ Copenhagen, Copenhagen, Denmark
[5] Humanitas Univ, Milan, Italy
[6] IRCCS Humanitas Res Hosp, Milan, Italy
[7] Natl Taiwan Univ Hosp, Taipei, Taiwan
[8] Univ Helsinki, Helsinki, Finland
[9] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland
[10] Charles Univ Prague, Prague, Czech Republic
[11] Univ Milan, Milan, Italy
[12] Ist Nazl Tumori, Fdn Ist Ricovero & Cura & Carattere Sci IRCCS, Milan, Italy
[13] Univ Ziekenhuis, Ghent, Belgium
[14] F Hoffmann La Roche Ltd, Basel, Switzerland
[15] Hoffmann La Roche Ltd, Mississauga, ON, Canada
[16] La Roche Prod Ltd, Welwyn Garden City, Herts, England
[17] Hosp Civils Lyon, Pierre Benite, France
[18] Univ Claude Bernard, Pierre Benite, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7020
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Combination of Idasanutlin, Venetoclax and Obinutuzumab in Patients with Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL): Results from a Phase I/II Study
    Kamdar, Manali
    Augustson, Bradley
    Rok, Young
    Edwards, James
    Hertzberg, Mark
    Johnston, Amanda
    Kim, Jin Seok
    Kroschinsky, Frank P.
    Smith, Sonali M.
    Stevens, Don A.
    Monnet, Annabelle
    Zhao, Ye
    Nouet, Yann
    Marinova, Viktoriya
    BLOOD, 2020, 136
  • [2] Glofitamab monotherapy in patients with heavily pretreated relapsed/refractory (R/R) mantle cell lymphoma (MCL): Updated analysis from a phase I/II study
    Phillips, Tycel Jovelle
    Carlo-Stella, Carmelo
    Morschhauser, Franck
    Bachy, Emmanuel
    Crump, Michael
    Trneny, Marek
    Bartlett, Nancy L.
    Zaucha, Jan
    Wrobel, Tomasz
    Offner, Fritz
    de L'Etang, Audrey Filezac
    Relf, James
    Carlile, David J.
    Byrne, Ben
    Mulvihill, Estefania
    Lundberg, Linda
    Dickinson, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Safety and Efficacy of Tinostamustine in Heavily Pre-Treated Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)
    Ghesquieres, Herve
    Pinto, Antonio
    Sureda, Anna
    Tournilhac, Olivier
    Morschhauser, Franck
    Janik, Tomas
    Zinzani, Pier Luigi
    BLOOD, 2021, 138
  • [4] Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    William, Basem M.
    Hohenstein, Maribeth
    Loberiza, Fausto R., Jr.
    Caponetti, Gabriel C.
    Bociek, R. Gregory
    Bierman, Philip
    Armitage, James O.
    Chan, Wing-Chung
    Vose, Julie M.
    BLOOD, 2010, 116 (21) : 131 - 131
  • [5] Phase I study of CC-90011 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
    Hollebecque, A.
    de Bono, J. S.
    Plummer, R.
    Isambert, N.
    Martin-Romano, P.
    Baudin, E.
    Mora, S.
    Filvaroff, E.
    Lamba, M.
    Nikolova, Z.
    ANNALS OF ONCOLOGY, 2019, 30 : 9 - 9
  • [6] Phase I study of CC-90011 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
    Hollebecque, A.
    de Bono, J.
    Plummer, R.
    Isambert, N.
    Martin-Romano, P.
    Baudin, E.
    Mora, S.
    Harding, A.
    Nguyen, A.
    Filvaroff, E.
    Lamba, M.
    Liu, K.
    De Alvaro, J.
    DiMartino, J.
    Zuraek, M.
    Nikolova, Z.
    ANNALS OF ONCOLOGY, 2018, 29
  • [7] Phase I study of CC-90010 in patients with advanced solid tumours and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
    Moreno, V.
    Brana, I.
    Sepulveda Sanchez, J. M.
    Vieito Villar, M.
    Hernandez-Guerrero, T.
    Doger, B.
    Saavedra, O.
    Italiano, A.
    Michot, J-M.
    Musuraca, G.
    Asierto, P. A.
    Carlo-Stella, C.
    Sarmiento, R.
    De Alvaro, J.
    Di Martino, J.
    Zuraek, M.
    Sanchez Perez, T.
    Filvaroff, E.
    Hanna, B.
    Nikolova, Z.
    ANNALS OF ONCOLOGY, 2019, 30 : 438 - 438
  • [8] Phase I study of CC-90010 in patients with advanced solid tumors and relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
    Moreno, Victor
    Brana, Irene
    Sepulveda Sanchez, Juan Manuel Manuel
    Vieito Villar, Maria
    Hernandez-Guerrero, Tatiana
    Doger, Bernard
    Saavedra, Omar
    Ferrero, Olga
    Sarmiento, Rafael
    Arias, Marina
    De Alvaro, Juan
    DiMartino, Jorge F.
    Zuraek, Marlene
    Sanchez Perez, Tania
    Filvaroff, Ellen
    Aronchik, Ida
    Lamba, Manisha
    Hanna, Bishoy
    Nikolova, Zariana G.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Safety and Efficacy of Tinostamustine in Pre-Treated Patients with Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL): Early Results from an Additional Expansion Cohort of a Phase I Study
    Sureda, Anna
    Pinto, Antonio
    Ghesquieres, Herve
    Morschhauser, Franck
    Tournilhac, Olivier
    Mutseaers, Pim
    Zijlstra, Josee M.
    De Jong, Floris A.
    Janik, Tomas
    Zinzani, Pier Luigi
    BLOOD, 2022, 140 : 3696 - 3697
  • [10] Phase I study of CC-90011 in patients with advanced solid tumours (STs) and relapsed/refractory non-hodgkin lymphoma (R/R NHL)
    Hollebecque, A.
    de Bono, J. S.
    Salvagni, S.
    Plummer, R.
    Isambert, N.
    Niccoli, P.
    Capdevila, J.
    Curigliano, G.
    Moreno, V.
    De Braud, F. G. M.
    Lopez-Brea, M.
    Martin-Romano, P.
    Baudin, E.
    Arias, M.
    de Alvaro, J.
    Parra-Palau, J.
    Sanchez Perez, T.
    Filvaroff, E.
    Lamba, M.
    Nikolova, Z.
    ANNALS OF ONCOLOGY, 2019, 30
12345